Silymarin Protects the Liver from Anti-Tuberculosis Drug Toxicity
Author Information
Author(s): Eminzade Sude, Uras Fikriye, Izzettin Fikret V
Primary Institution: Marmara University, Faculty of Pharmacy
Hypothesis
Does silymarin provide protective effects against hepatotoxicity caused by anti-tuberculosis drugs?
Conclusion
Silymarin has protective effects against the liver damage caused by anti-tuberculosis drugs in animal models.
Supporting Evidence
- Silymarin significantly decreased the biochemical and histological changes induced by anti-tuberculosis drugs.
- Serum ALT, AST, and ALP activities were elevated in drug-treated animals, indicating liver damage.
- Co-administration of silymarin improved liver function markers compared to those treated with drugs alone.
Takeaway
Silymarin, a plant extract, helps protect the liver from damage caused by certain tuberculosis medications.
Methodology
Male Wistar albino rats were divided into six groups and treated with various combinations of anti-tuberculosis drugs and silymarin, followed by biochemical and histopathological assessments.
Limitations
The study was conducted on animal models, and results may not directly translate to humans.
Participant Demographics
Male Wistar albino rats weighing 250–300 g.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website